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Abstract
Imputation-based association methods provide a powerful framework for testing untyped variants for association with
phenotypes and for combining results from multiple studies that use different genotyping platforms. Here, we consider
several issues that arise when applying these methods in practice, including: (i) factors affecting imputation accuracy,
including choice of reference panel; (ii) the effects of imputation accuracy on power to detect associations; (iii) the relative
merits of Bayesian and frequentist approaches to testing imputed genotypes for association with phenotype; and (iv) how
to quickly and accurately compute Bayes factors for testing imputed SNPs. We find that imputation-based methods can be
robust to imputation accuracy and can improve power to detect associations, even when average imputation accuracy is
poor. We explain how ranking SNPs for association by a standard likelihood ratio test gives the same results as a Bayesian
procedure that uses an unnatural prior assumption—specifically, that difficult-to-impute SNPs tend to have larger effects—
and assess the power gained from using a Bayesian approach that does not make this assumption. Within the Bayesian
framework, we find that good approximations to a full analysis can be achieved by simply replacing unknown genotypes
with a point estimate—their posterior mean. This approximation considerably reduces computational expense compared
with published sampling-based approaches, and the methods we present are practical on a genome-wide scale with very
modest computational resources (e.g., a single desktop computer). The approximation also facilitates combining
information across studies, using only summary data for each SNP. Methods discussed here are implemented in the
software package BIMBAM, which is available from http://stephenslab.uchicago.edu/software.html.
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Introduction
Ongoing large-scale genetic association studies, in an attempt to
identify variants and genes affecting susceptibility to common
diseases, are typing hundreds of thousands of SNPs in thousands of
individuals, and testing these SNPs for association with phenotypes.
Although this is a large number of SNPs, an even larger number of
SNPs remain untyped. For example, the International HapMap
Project contains genotype data on more than 3 million SNPs [1],
many of which will not be typed in current studies. Imputation-
based association analysis [2,3] provides a powerful framework for
testing these untyped variants for association with a phenotype.
The idea behind these imputation-based approaches is to
exploit the fact that untyped SNPs are often correlated with typed
SNPs, so genotype data on typed SNPs can be used to indirectly
test untyped SNPs for association with phenotypes. Specifically,
the approaches in [2,3] exploit available information about
patterns of correlation among typed and untyped SNPs in a
reference panel of densely-genotyped individals (e.g. the HapMap
samples) to explicitly predict, or ‘‘impute’’, the genotypes at
untyped SNPs in a study sample, and then test these imputed
genotypes for association with a phenotype, taking account of
uncertainty in the imputed genotypes. We emphasise this last
point, because imputation could be interpreted as testing a single
estimate of the genotypes (as in [4], for example), ignoring
uncertainty, whereas we take a broader interpretation, to include
methods that incorporate uncertainty in imputed genotypes.
Testing untyped variants via imputation both increases power to
detect associations [2,3] and provides improved explanations for
detected associations, for example by helping to identify the most
plausible causal variant or variants [2]. Imputation also provides a
powerful framework for combining information across multiple
association studies performed on different genotyping platforms,
since it allows each study to test the same set of SNPs regardless of
the genotyping platform used (e.g. [5,6]).
Here we focus on several important issues that arise when
applying imputation-based methods in practice. These include i)
factors affecting imputation accuracy, including choice of
reference panel; ii) the effects of imputation accuracy on power
to detect associations; iii) the relative merits of Bayesian and
frequentist approaches to testing imputed genotypes for association
with phenotype; and iv) how to quickly and accurately compute
Bayes factors for testing imputed SNPs.
We find that imputation-based methods can be relatively robust
to imputation accuracy: small changes in imputation accuracy
produce small changes in power to detect associations, and even
when average imputation accuracy is poor (as could occur if the
panel is not well-matched to the study sample), imputation-based
approaches can still improve power compared with no imputation.
Comparing frequentist and Bayesian methods for testing imputed
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ratio test gives the same results as a Bayesian procedure based on a
particular prior assumption–specifically that difficult-to-impute
SNPs tend to have a larger effect on phenotype. We argue that
since this assumption is unnatural, alternative Bayesian approaches
that do not make this assumption should have an advantage, in
principle, for testing untyped SNPs. We illustrate the practical effect
of this advantage via simulation experiments. Within the Bayesian
framework we find that good approximations to a full analysis can
be achieved by simply replacing unknown genotypes with a point
estimate, their posterior mean. This approximation produces results
that are more accurate, and orders of magnitude faster to compute,
than sampling-based estimates used by [2,3]. Indeed, the resulting
approximation is faster, even, than application of standard
frequentist methods in this context, and the methods we discuss
are fast enough to be practical on a genome-wide scale with very
modest computational resources (e.g. a single desktop computer).
The accuracy of this approximation also has helpful implications for
combining information across studies in situations where only single
SNP summary data can be easily shared.
Imputation-Based Association Mapping
We now describe more formally the imputation-based ap-
proaches to association mapping that we take here, and introduce
notation for use in later sections. Readers whose primary interest is
in our practical findings may wish to skip the Results section, and
refer back to this section for reference.
The imputation-based approach we take here is based on using a
‘‘prospective’’ model relating phenotypes to genotypes, and so is
appropriate for analyzing phenotypes and genotypes on individuals
sampled randomly from a population. We consider its applicability
to other designs, such as case-control studies, in the Discussion. (See
[4] for related work based on a retrospective likelihood.)
LetY denote measuredphenotypevaluesfor nrandomly-sampled
individuals on whom genome-scan genotype data G have been
collected. We use yi to denote the phenotype of individual i,a n dg ij
for the genotype of individual i at SNP j (coded as 0, 1 or 2 copies of
the minor allele), with g?j denoting the vector of genotypes at SNP j.
We also assume the availability of denser genotype (or haplotype)
data, H, on a ‘‘panel’’ of unrelated, unphenotyped, individuals. In
our examples this panel will consist of subsets of individuals fromthe
International HapMap Project. For notational simplicity we assume
that the columns of H and G are augmented, as necessary, so that
theyrefer tothe same setofSNPs (i.e.sothey havethe samenumber
of columns, with the jth columnof each referringto the same SNPj).
Thus, if a SNP j is typed in H but not in G then g?j will consist of all
‘‘missing’’ observations.
The aim of our imputation-based mapping approach is to assess
whether a SNP, j, that is genotyped in H but not in G, is associated
with the phenotype Y. Let b denote the parameters in a model that
relates phenotypes Y with genotypes g?j at SNP j. To obtain a
likelihood for b, given the observed data Y, G, H, we take the
standard regression-based approach of conditioning on the
genotypes G, H, and using the conditional distribution p(Y|G, H,
b) as the likelihood. This approach implicitly assumes that the
genotypes alone contain no information about b (or, at least, it
ignores any such information). [Although in principal the genotypes
alone could provide information about whether a SNP has an effect
on phenotype (e.g. through signatures of selection), such informa-
tion seems likely to be both limited, and difficult to extract.] Under
this assumption the likelihood for b can be written as
L b;Y ðÞ : ~pYG ,H,b j ðÞ
~
X
g
pYg:j
    ~g,G,H,b
  
Pr g:j~g G,H,b j
  
~
X
g
pYg:j
    ~g,b
  
Pr g:j~g G,H j
  
,
ð1Þ
where the last line invokes the assumption that the genotype
distribution does not depend on b.
From Expression (1) we see that, for an untyped SNP, the
likelihood is a weighted average of the complete data likelihood
(i.e. the likelihood if the genotypes at SNP j were observed to be g?j)
over all possible values of g?j. The weights, Pr(g?j=g|G, H), are
determined by the distribution of the unobserved genotypes given
the observed genotypes (which can be obtained in several ways;
here we use methods from [7]). This sum has too many terms to be
computed directly. However, if the two distributions that occur in
each term of this sum are independent across individuals, as they
will be in settings considered here, then the likelihood simplifies to
a computationally-tractable form:
L b;Y ðÞ ~ P
n
i~1
X 2
k~0
py i gij
    ~k,b
  
Pr gij~kG ,H j
  
: ð2Þ
We will compare two different approaches to using this
likelihood to test the null hypothesis H0 that SNP j is unassociated
with phenotype, versus the alternative hypothesis H1 that SNP j is
associated with phenotype. The first approach is to use the
generalized likelihood ratio test statistic,
L~L b b b1;Y
   .
L b b b0;Y
  
, ð3Þ
where b ˆ
0 and b ˆ
1 denote the maximum likelihood estimates of b
under H0 and H1 respectively. Under standard theory, 2log(L) has
an asymptotic x
2 distribution under H0.
The second approach we consider is the Bayesian approach
from [2]. In Bayesian statistics, the strength of the evidence for H1
vs H0 is given by the Bayes factor for H1 vs H0, defined as
BF~pYH 1 j ðÞ =pYH 0 j ðÞ
~
ð
L b;Y ðÞ p1 b ðÞ db
 ð
L b;Y ðÞ p0 b ðÞ db,
ð4Þ
where p0 (?) and p1 (?) denote prior distributions on b under H0 and
H1. Note that this expression for the Bayes factor bears some
Author Summary
Genotype imputation is becoming a popular approach to
comparing and combining results of multiple association
studies that used different SNP genotyping platforms. The
basic idea is to exploit the fact that, due to correlation
among untyped and typed SNPs, genotypes of untyped
SNPs in each study can be inferred (‘‘imputed’’) from the
genotypes at typed SNPs, often with high accuracy. In this
paper, we consider several issues that arise when applying
these methods in practice, including factors affecting
imputation accuracy, the importance of taking account of
imputation uncertainty when testing for association
between imputed SNPs and phenotype, how imputation
accuracy affects power, and how to combine results across
studies when only single-SNP summary data can be shared
among research groups.
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numerator and denominator are maximised with respect to
unknown parameters b, in the Bayes factor they are integrated with
respect to these parameters, weighted by the prior (which has the
effect of averaging over plausible values of the parameters). Large
values of the Bayes factor indicate evidence for H1 over H0,
whereas small values indicate evidence for H0 over H1. Bayes
factors have a number of general advantages over p values as
measures of evidence [2,8,9], and, as we show below, a particular
advantage, at least in principle, when testing untyped SNPs.
For a typed SNP at which genotypes are observed to be g, the
Bayes factor, BF(g), can sometimes be computed analytically (see
below). For an untyped SNP the Bayes factor is the weighted
average of BF(g) over all possible values for g. Indeed, substituting
the likelihood (1) into the numerator of (4) gives
BF~
X
g
ð
pYg:j
    ~g,b
  
p1 b ðÞ db
  
Pr g:j~g G,H j
   .
pYH 0 j ðÞ
~
X
g
BF g ðÞ Pr g:j~g G,H j
  
:
ð5Þ
Since this sum typically has too many terms to be computed
directly, it must be approximated by computational methods; we
compare three different methods later in this paper.
Example: Normal Phenotype
We now give explicit expressions for the likelihood and Bayes
factor in the case of a continuous (quantitative) phenotype Y,
which will be our primary focus for the rest of this paper. We
assume a normal linear model relating Y to the genotypes g?j at a
SNP j of interest:
yi~mzagijzd1 gij~1
  
zei ð6Þ
where m is the phenotype mean for individuals with gij=0;a and d
represent, respectively, an additive and dominance effect for SNP
j; 1(A) is the indicator function, taking value 1 if A is true, and 0
otherwise; and ei are independent and identically distributed
N(0,1/t) error terms, where 1/t represents the variance of Y within
each genotype class. Thus the parameters in this model are b=(m,
a, d, t), and the null hypothesis H0 is a=d=0.
Under this model, the likelihood (2) becomes, for each yi,a
mixture of three normal distributions:
L b;Y ðÞ ~P
i
X 2
k~0
Pr gij~kG ,H j
  
Ny i;ak,t ðÞ
"#
ð7Þ
where N(?;a, t) denotes the normal density with mean a and
variance 1/t, and a0=m, a1=m+a+d, a2=m+2a.
To compute Bayes factors, we use a prior based on prior D2
from [2]. Among other assumptions, this prior assumes that a and
d are independent and normally distributed, with mean 0, and
respective variances s2
a
 
t and s2
d
 
t. As noted by [2], the
assumption that a and d are a priori independent is not ideal,
since one might expect a and d to be dependent. However,
dependence can easily be introduced by averaging results from
prior D2 over several values of sa and sd, as we do here.
Furthermore, in simulations, [2] found that the results from this
prior generally agreed well with results from another prior, D1,
based on more realistic assumptions.
Under this prior, the Bayes factor for a SNP with genotypes g,
BF(g), can be computed analytically ([2], Protocol S1):
BF g ðÞ ~
n1=2
n{1zXtX jj
1=2
1
sasd
Yt I{X n{1zXtX
   {1Xt
  
Y
YtY{nY
2
2
4
3
5
{n=2 ð8Þ
where Y ¯ is the mean of the phenotypes Y; n
21 is the 363 diagonal
matrix with diagonal elements 0,s{2
a ,s{2
d
  
; and X is an n63
design matrix, which is a function of the genotypes g. Specifically,
the first column of X is a vector of 1s, the second column is the
vector of genotypes g, and the third column is a vector of
indicators for whether the genotypes are heterozygotes
(Xi3=1(gi=1)).
To compute the likelihood ratio (3) and Bayes factor (5) we now
need two things. First, we need expressions for Pr(g?j=g|G, H);
that is, we need to have ways to estimate the (distribution of)
genotypes at SNP j from the observed genotype data G, H. Second,
because the sum (5) is over all possible genotypes at SNP j, and
therefore typically contains a very large number of terms, we need
efficient computational methods for approximating this sum. (In
contrast, L can be obtained relatively easily by numerical
optimisation of (2) over b.) The first two sections of the results,
Genotype Imputation, and Bayes Factor Calculation, deal with
each of these two issues in turn. Subsequent sections deal with
comparisons of the use of the Bayes factor and L to detect
associations with phenotypes, and the effects of imputation
accuracy on power to detect associations.
Results
Genotype Imputation
While there are many possible approaches to predicting
unknown genotypes from patterns of LD [e.g. 10,11,12], both
[2,3] use similar methods based on Hidden Markov models: the
PAC model from [13] implemented in software PHASE and
IMPUTE, and the cluster-based model from [7] implemented in
software fastPHASE and BIMBAM. In comparisons in [7] the two
models produced very similar accuracy for imputed genotypes,
and were more accurate than other methods considered. Both
models also produced approximately calibrated predictions (e.g.
genotypes assigned a probability of 90% by these models were
correct in approximately 90% of cases). Here we focus on the
cluster-based model from [7] because it has certain computational
and practical advantages over the PAC model (e.g. it can deal
easily with unphased panel data). However, we expect many of our
conclusions to apply more generally (e.g. see Discussion).
In brief, the model from [7] assumes that each SNP along each
sampled haplotype has an (unknown) cluster membership that
changes, in a Markovian way, along the chromosome. Conditional
on cluster memberships, alleles are sampled independently from
cluster-specific and SNP-specific allele frequencies, h. Other
parameters of the model include the jump rates for cluster
memberships, r; and the probabilities of jumping to each cluster, a.
In the most general version of the model, which we consider here,
both r and a are allowed to vary along the genome; see [7] for full
details. [7] give an EM algorithm for estimating the parameters (h,
a, r) from either phased or unphased genotype data, and describe
how the model can be used to impute missing genotypes and
estimate haplotypic phase. For example, given parameter
Imputation-Based Association Mapping
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individual i at SNP j can be approximated as Pr(gij=g|gi?,h ˆ,a ˆ,r ˆ)
where gi? is the vector of observed genotypes in individual i.
[7] compared several approaches to genotype imputation using
data with genotypes missing at random. In their comparisons the
cluster-based model provided more accurate imputed genotypes
than other methods provided that i) the number of clusters was
sufficiently large, and ii) predictions of genotype probabilities were
averaged acrossmultiple applications oftheEMalgorithm. Herewe
examine factors affecting the accuracy of genotypes imputed using
this model in the context of imputation-based association mapping,
where patterns of missingness are highly structured, not random.
We took a genotype data, G, on chromosome 22 from 675
Caucasianindividuals enrolled in the PRINCE study [14] who have
been genotyped on the Illumina 317k chip as part of an ongoing
genome-wide association study to study statin response and lipid-
related phenotypes. To provide a set of test SNPs on which to assess
imputation accuracy we masked all 675 genotypes at every 25th
SNP (masking 220 SNPs in eachtrial, this procedure being repeated
5 times by shifting the starting SNP, so masking 1100 SNPs in total).
Wethenassessedvariousstrategiesforusingthe cluster-basedmodel
to impute the masked genotypes, using subsets of the HapMap data
as a panel, H. Except where noted, results here are based on using
the 60 HapMap CEU (European) parents as the panel. We assessed
accuracy of imputed genotypes by comparing the true genotypes
with the ‘‘best guess’’ imputed genotypes (i.e. the genotype assigned
the highest probability) and computing the genotype error rate,
being the proportion of best guess genotypes that are incorrect.
Methods of Parameter Estimation. Our first, most
striking, finding is that imputing genotypes using parameter
estimates obtained by maximising the full likelihood L(h, a, r; G,
H)=Pr(G, H|h, a, r) performs much less well than imputing
genotypes using parameter estimates obtained by maximising the
likelihood for H only, L(h, a, r; H)=Pr(H|h, a, r). For example,
when using the CEU HapMap parents (phased data) as a panel,
the genotype error rates for these two strategies were, respectively,
,12% vs ,6%. The poor performance of the former strategy is
not simply due to the EM algorithm getting stuck in poor local
modes in the likelihood surface for the larger data set: after first
fitting the model to H only, applying additional iterations of the
EM algorithm with the full data G, H also worsened imputation
accuracy (data not shown).
These results may appear initially counter-intuitive. However, we
note that in the available data, only H contains information about
patterns of LD between typed and untyped SNPs, which is the
relevant information when using typed SNPs to impute untyped
SNPs. For example, if genotypes at SNPs A and B are predictive of
genotypes at a SNP C,a n dA and B are typed in the cohort, but C is
untyped, then all that matters for predicting genotypes at C is the
conditional distribution Pr(gC|gA,gB) (in an obvious notation); in
particular, information on LD between A and B is irrelevant. The
cohort data G, which contain data on only the typed SNPs A and B,
do not contain information about this conditional distribution, and
so including G in the model fit cannot improve imputation accuracy
at C. This explains why including G in the model fit does not
improve imputation accuracy, and also supports the strategy used
by [3], who perform imputation for each cohort individual
independently conditional only on the panel data. It does not
however fully explain why including G in the model fit actually
worsens imputation accuracy. A possible explanation for this is that
fitting the model to G and H effectively reduces the number of
clusters available to model H, since some are ‘‘stolen’’ by the large
number of individuals in G, and it is this effective reduction in the
number of clusters that worsens imputation accuracy. (Note that
onemightexpectincludingGinthe modelfittoimprove imputation
accuracy at sporadically missing genotypes at typed SNPs in G—as
opposed to systematically missing genotypes at untyped SNPs that
are the main focus of imputation—since here LD among typed
SNPs is what matters, and G contains information on this. In
separate experiments (results not shown) we did observe that fitting
the model using (G, H) produced a small improvement in this typeof
imputation accuracy compared with fitting it to H alone.)
Besides increasing imputation accuracy at untyped SNPs, fitting
the model to H alone has the happy consequence of considerably
reducing computational expense, particularly in studies with many
individuals. This computational saving is due both to the reduced
number of individuals in H compared with H, G, and to the fact that
H can often be assumed phase-known (computational cost for phased
data is linear in K, whereas for unphased data it is quadratic in K).
Number of Clusters and EM Iterations. We found that
accuracy of imputed genotypes improved with increased number
of clusters (K), and with the number of EM runs over which results
were averaged (E); see Table 1. However, differences in genotype
accuracy across different values of these parameters were relatively
minor (error rates all lay in the range 6.2%–7.3%). Substantially
increasing the number of clusters, to 100, produced essentially the
same accuracy as using 30 clusters (data not shown). We also
experimented with increasing the number of iterations per EM run
to improve convergence of parameter estimates during the model
fitting procedure, but this did not consistently improve accuracy
(error rates typically changed by less than 0.1%, sometimes
increasing, sometimes decreasing).
Comparison with IMPUTE. We compared imputation
accuracy with that of the PAC model, used by [3], implemented
in the software IMPUTE. For these data IMPUTE produced an
error rate of 6.6% (X. Wen, personal communication), very similar
to the results from our approach, confirming the finding from [7]
that the two models produce very similar genotype accuracy, at
least provided K in the cluster-based model is set appropriately,
and the cluster-based model is fitted only to H. (Note that the data
we consider here come from chromosome 22, which has an above-
average recombination rate, and hence below-average linkage
disequilibrium. This is expected to make imputation harder than
in typical genomic regions, and may partly explain why error rates
reported here are slightly higher than in [3].)
Table 1. Error rates (proportion of cases where the most
probable genotype does not match the true genotype) for
different genotype imputation strategies, using the model of
[7] and the (phased) CEU HapMap parents as a panel.
Number of Clusters Number of EM runs Error Rate
K=10 E=5 0.073
K=10 E=10 0.072
K=10 E=20 0.069
K=20 E=5 0.068
K=20 E=10 0.064
K=20 E=20 0.064
K=30 E=5 0.064
K=30 E=10 0.063
K=30 E=20 0.062
We use K to denote the number of clusters used, and E to denote the number
of EM runs over which genotype probabilities are averaged. In each case we
used 10 iterations of the EM algorithm in each run.
doi:10.1371/journal.pgen.1000279.t001
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over the PAC model is that it can easily deal with the situation
where the panel of densely-genotyped individuals is unphased,
whereas the PAC model is much harder to adapt to that setting
(e.g. IMPUTE assumes that a phased panel is available). Since the
HapMap provides many accurately phased individuals, this
advantage will not always be important. However, it does make
it easier to exploit any denser unphased genotype data that may be
available in some cases (e.g. from resequencing of a candidate
region). Motivated by this, we examined the effect of having an
unphased panel, by performing imputation with the model fit to
the unphased CEU HapMap parents. Compared with having a
phased panel, the error rates for the unphased panel were
consistently a few tenths of a percent higher (e.g. 7.6% vs. 7.2% for
E=10, K=10).
Mismatched Panel. We examined the effect of having a
panel that is not well matched to the sample, by using the African
(YRI) and Asian (CHB+JPT) HapMap samples as a panel to
impute genotypes in the European individuals. We found that
using either of these panels individually substantially increased
error rates (17% for CHB+JPT, 25% for YRI). However, using a
combined panel of CEU+YRI+CHB+JPT gave an error rate only
slightly higher than using CEU alone (7.8% for combined panel
vs. 6.2–7.3% for CEU). This demonstrates that imputation
accuracy can be relatively robust to mismatches between the
panel and cohort samples, provided that the panel contains at least
some individuals with genetic variation representative of the
cohort. For intuition into why this happens, note that to impute an
individual’s genotypes, the cluster-based model (and, indeed, the
PAC model) attempts to explain the individual’s observed
genotypes using a mosaic of panel haplotypes. This can work
provided the panel contains suitable haplotypes, even if the panel
also contains a large number of unsuitable haplotypes. Thus,
although the issue of panel choice merits further study, using the
combined panel should be a helpful strategy when imputing
genotypes in a cohort that may not be well represented by a single
HapMap analysis panel (e.g., admixed individuals).
Trade-Off between Accuracy and Call Rate. The error
rates above are average error rates across all SNPs, assuming all
genotypes are called (i.e. 100% call rate). Both the PAC and
cluster-based models provide, for each genotype, a probability for
each of the three possibilities. If we consider only those genotypes
assigned a high probability then error rates can be substantially
reduced, at the expense of reduced call rate. For example, if we
call only those genotypes assigned a probability of at least 90%
then the error rate is reduced to 1%, with a call rate of 74%.
Figure 1 shows the correspondance between call rate and accuracy
for these data. Although we have used different data, and different
approaches to imputation, the results are rather similar to the
analogous results in [3] (their Figure 1).
Bayes Factor Calculations
The Bayes factor for an untyped SNP (Equation (5)) involves a
sum over a very large number of terms, and it is computationally
impractical to compute this sum directly. In practice then we must
use methods to approximate this Bayes factor. Here we compare
three different approaches to making this approximation.
The first appproach is the ‘‘naive’’ Monte Carlo estimator used
by both [2,3], given by:
BFnaive~
1
M
X M
m~1
BF g m ðÞ
  
ð9Þ
where g
(1),…,g
(M) are independent and identically-distributed
samples from Pr(g?j|G, H). For sufficiently large M this estimator
will give an accurate approximation to the BF (5). More precisely,
it converges to the true value as MR‘. However, in practice we
have found that for moderate values of M (=1,000 say) this
estimator can have a large standard deviation, producing
unreliable estimates for some SNPs (see below).
The second approach is based on an importance sampling
estimator [e.g. 15]:
BFIS~
1
M
X M
m~1
BF g m ðÞ
  
Pr g m ðÞ G,H j
   .
Q g m ðÞ
  
ð10Þ
where g
(1),…,g
(M) are independent samples from an ‘‘importance
sampling distribution’’ Q(?). With judicious choice of Q the
standard deviation of this estimator, and hence the accuracy of
the approximation, can be much improved compared with BFnaive.
Our importance sampling function is described in Text S1.
The third approach we consider is motivated by the simple idea
of replacing unobserved genotypes at SNP j with their posterior
mean, and computing a Bayes factor based on these posterior
mean genotypes. To describe this approach more precisely, note
that the Bayes factor for a typed SNP can be written as a function
of a design matrix X (equation (8)). The approximation we
consider is to replace X with its expected value, X ¯ (so in the second
column of X each element gij is replaced with E(gij|G, H), and in
the third column I(gij=1) is replaced with Pr(gij=1|G, H)) and to
compute an approximate Bayes factor, BFmean, based on this
expected design matrix:
BFmean~BF X
  
: ð11Þ
Since the elements of X ¯ can be computed analytically (using either
the PAC or cluster-based model) the approximation BFmean is very
Figure 1. Graph showing the trade-off between call-rate and
error rate, as the probability threshold for calling an imputed
genotype is varied. Numbers along the line indicate the thresholds
that produce the corresponding call rate and error rate; small black
points indicate results for intermediate thresholds in increments of 0.02.
For example, if we call only those imputed genotypes assigned
probability .0.9 of being correct, then approximately 74% of imputed
genotypes are called, and of these called genotypes approximately 1%
are incorrect.
doi:10.1371/journal.pgen.1000279.g001
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evaluations by a factor of M (and thus, typically, reducing
computation for each SNP by orders of magnitude, once
imputation has been performed) compared with BFnaive and BFIS.
We compared the three approximations by applying them to
the genome-scan genotype data on chromosome 22, described
above, with phenotypes simulated under both null and alternative
hypotheses (see next section for details). Bayes factors were
computed by averaging over sa=0.05, 0.1, 0.2, 0.4 and sd=sa/4.
For the sampling-based estimators BFnaive and BFIS we used
M=1,000. Values of BFmean were generally similar to both BFIS,
and BFnaive (Figure 2), with the agreement with BFIS being better
(presumably because BFIS has generally smaller standard error
than BFnaive; see red vertical bars on Figure 2). Furthermore, at
SNPs where the values disagreed most strongly, the standard error
of the Monte-Carlo estimators tended to be large (see red vertical
bars on Figure 2), suggesting that at these SNPs the Monte-Carlo
estimates may be unreliable. In summary, BFmean appears to
provide an adequate approximation to the Bayes factor, more
accurate (for M=1,000) than the naive Monte Carlo estimates
used by [2,3], and orders of magnitude quicker to compute.
To explain why, and under what circumstances, BFmean
provides an accurate approximation to the Bayes factor for H1
vs H0, note that BFmean is, in fact, the Bayes factor for a different
alternative hypothesis H’1,
yi G,H j ~mzE gij G,H j
  
azPr gij~1 G,H j
  
dzei ð12Þ
where ei are independent and identically distributed N(0,1/t). The
likelihood for this alternative hypothesis H’1 is very similar to the
likelihood for H1 (Equation 7). In particular Yi has the same mean
underH’1 andH1.Thedifferencesbetweenthetwoarethati)under
H’1, Yi is normal, whereas under H1 it is a mixture of three normals;
and ii) under H’1 the variance of Yi is the same for each i, whereas
under H1 the variance of Yi is larger for those i whose genotypes are
less certain. These differences will be subtle unless a and d are large
compared with 1/t (since with small a and d the three components
of the mixture will have similar means, making the mixture of
normals very similar in shape to a normal, and ensuring that
differences among individuals in variance of Yi are small). In
particular, our empirical results suggest that, at least for priors with
sa,0.4, BFmean generally provides an accurate approximation to
the full Bayes factor. For different priors, using substantially larger
values of sa, we have seen examples where the accuracy of the
approximation is much poorer (data not shown). However, in
genome-wide association studies, where effect sizes of single SNPs
tend to be small, the use of such large values of sa will not generally
be desirable or appropriate (although see next section).
We note that it would be relatively straightforward to develop an
improved approximation to the Bayes factor for H1 by modifying
H’1 to account for the different variances across i. We do not pursue
this here since BFmean appears adequate for our purposes.
In subsequent sections we use BFmean to approximate the Bayes
factor. Motivated by the fact that BFmean is the Bayes factor for
H’1 vs H0, we will also consider an analogous likelihood ratio
statistic, Lmean, defined to be the likelihood ratio statistic for H’1 vs
H0. The statistic Lmean has several practical advantages over L:i t
can be computed analytically (Text S2), which results in a
moderate computation saving (a factor of around 10–20 in our
implementation, although the exact saving will depend on the
details of the numerical optimisation scheme used to obtain L);
and Lmean can be easily obtained from standard regression
software since H’1 is a standard linear regression. (In terms of
ranking SNPs in order of significance, Lmean is equivalent to the
standard F statistic for this regression.)
Choice of Test Statistic for Imputation-Based Analyses
In this section we use both theoretical arguments and simulation
experiments to compare and contrast the use of Bayes factors vs p
values from likelihood ratio statistics for testing untyped SNPs for
association.
Theoretical Comparison. Several authors have pointed out
advantages of Bayes factors over p values as measures of evidence
(see for example, in this context, [2,3,8]). These advantages, which
apply to both typed and untyped (imputed) SNPs, include many
advantages of interpretation. For example, although p values have
a straightforward interpretation in principle, they are notorious for
being mis-interpreted in practice [16]. Further, the strength of the
evidence represented by a particular Bayes factor tends to be less
sensitive to context than the evidence represented by a particular p
Figure 2. Graphs showing correspondence of BFmean (x-axis) vs BFIS (y-axis on left panel) and BFnaive (y-axis on right panel). In each
case the diagonal blue line is y=x, and the vertical red lines indicate 62 standard errors of the Bayes factor estimate (for example, on the left they run
between log10(BFIS62 standard errors)).
doi:10.1371/journal.pgen.1000279.g002
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of, say, 10
5 is truly associated with the phenotype is the same
whether the Bayes factor was computed from a sample of 100 or
10,000 individuals; whereas the probability that a SNP with a p
value of, say, 10
26 is truly associated with phenotype will be
different in these two settings. In addition it is often desirable, and
straightforward, to combine (by averaging) Bayes factors
computed under different assumptions (e.g. averaging over
additive and dominant models for effects, and thus allowing for
dominance while maintaining some of the benefits of simpler
additive models). However, in terms of the limited question of
simply ranking SNPs for association with phenotype, [17] shows
that, under an additive model (no dominance), standard single-
SNP p values provide the same ranking of SNPs as a particular
Bayesian analysis. Specifically, these p values give the same
ranking as is obtained from Bayes factors computed under the
assumption that, under H1, the (prior) variance of effect sizes (s2
a in
this paper) is proportional to the variance of the maximum
likelihood estimator (MLE) of the additive effect a at that SNP.
Actually, [17] proves this result for a particular approximate Bayes
factor and frequentist test statistic (the Wald statistic) in the setting
of a logistic regression model; our Text S2 proves the analagous
result for BFmean and Lmean for the normal linear model.
However, we expect that the result will hold more generally; see
below for further discussion.
We now provide a practical interpretation of these results for
typed and untyped SNPs.
For typed SNPs, the variance of the MLE is approximately
proportional to 1/f(12f), where f is the SNP minor allele frequency
(MAF). Thus, as [17] points out, the result says that ranking SNPs
by p values (from the Wald statistic, or Lmean) can be thought of as
making the implicit assumption that effect sizes tend to be larger
for SNPs with a small MAF, and specifically that the expected
square of the effect size is proportional to 1/f(12f). Although we
know of no strong evidence for this particular assumption, the
general idea that rare SNPs may have larger effects is somewhat
biologically plausible, providing a possible rationale for the use of p
values in ranking typed SNPs for association.
For untyped SNPs, the variance of the MLE depends not only on
the MAF, but also on the confidence with which the untyped SNP
genotypes are imputed: the larger the uncertainty in imputed
genotypes, the larger the variance of the MLE. Thus, in addition to
the assumption for typed SNPs, ranking untyped (imputed) SNPs by
p values (from the Wald statistic or Lmean) can be thought of as
making the implicit assumption that the harder a SNP is to impute, the
larger its expected effect size. This assumptionseems hard to argue for on
any grounds, and we believe that this explains the results in
simulations below, where L and Lmean show slightly poorer
performance than Bayes factors that do not make this assumption.
Empirical Comparisons. To complement the above
theoretical arguments, we compared methods empirically, using
the real chromosome 22 genotype data described above and
simulated phenotype data. To make the comparison as focussed as
possible we compare results from the likelihood ratio statistics, L
and Lmean, with the Bayes factor BFmean based on the implicit
prior assumed by the likelihood ratio statistic. That is, we used a
prior in which the expected square of the effect size, s2
a,i s
proportional to 1/f(12f) (where f is the SNP MAF, estimated from
the panel data). Specifically we averaged Bayes factors over four
values, sa~K
  ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
f 1{f ðÞ
p
with K=0.05,0.1,0.2,0.4. (Note that for
the small proportion of SNPs with very small f this produces very
large values of sa for which the mean genotype approximation that
we are using may not provide a very accurate approximation to
the full Bayes factor. This presumably reduces power slightly
compared with what could be achieved using a better
approximation.) All statistics were computed under a pure
additive model (d=sd=0).
The key point here is that the priors for the Bayesian approach
were chosen so that, under the theory outlined above, the Bayesian
and frequentist test statistics will provide the same rankings for
typed SNPs. Thus any difference between the methods in ranking
SNPs must be due to differences in the treatment of untyped
imputed SNPs.
We simulated phenotype data under two scenarios. The first
scenario makes the assumption (also made by the testing methods)
that the additive effect at the causal SNP depends on MAF
a~0:1
  ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
f 1{f ðÞ
p   
. The second scenario assumes that the effect
size is constant, independent of MAF (a=0.2). These values of a
provide modest power to detect effects with the sample size
(n=675) we use here. Both scenarios assumed no dominance,
d=0, consistent with the assumptions made in computing the
statistics. For each value of a we simulated 1100 sets of phenotypes.
Each set of phenotypes was simulated by selecting a masked SNP
to be the ‘‘causal’’ variant, and then generating phenotype values
according to equation 6. This essentially creates 1100 independent
genome scan datasets, for chromosome 22 only, each containing a
single causal variant.
We applied imputation-based association mapping to each
dataset, using the HapMap CEU individuals as a panel, and
computing test statistics (BFmean, L and Lmean) for each typed and
untyped SNP. To examine effects of lower average imputation
accuracy (and confidence) we repeated this experiment using the
YRI individuals as a panel. In each case the causal variants were
assumed to be untyped (i.e., the genotypes at the causal variant
were assumed to be unknown, and were imputed along with all
other untyped SNPs). To compute L we used numerical
maximisation (Nelder-Mead) to maximise the numerator, with
initial parameter values obtained from maximising the alternative
likelihood (12). The computation for one simulated phenotype
(34083 test statistics) for BFmean, L and Lmean take 20 seconds,
229 seconds, and 10 seconds respectively, after imputed genotype
probabilities had been computed.
Figure 3 illustrates the relationships between BFmean and
L,Lmean, and how they depend on imputation confidence. (The
relationships with L and Lmean are qualitatively similar, but the
relationship with Lmean is cleaner because of the mathematical
relationship between BFmean and Lmean given in Text S2). Where
SNPs are easy to impute, with high confidence genotypes (black in
Figure 3), the Bayes factor and Likelihood ratio statistics have an
almost monotonic relationship, as predicted by the theory. For
difficult-to-impute SNPs, with low confidence genotypes, (e.g., red
in Figure 3) the qualitative behaviour of the statistics differs. The
Bayes factor tends to take values close to 1 (log(BFmean) close to 0),
with the variance about 1 being smallest for those SNPs with the
lowest confidence genotypes. This reflects the fact that these
difficult-to-impute SNPs tend to be relatively uninformative
regarding the null vs alternative hypotheses. In contrast, by design,
the likelihood ratio statistics have approximately the same
distribution (under the null) for both poorly-imputed and well-
imputed SNPs. The practical effect of this is that, when testing
difficult-to-impute SNPs, the Bayes factor is less likely to take a large
value by chance than is the likelihood ratio statistic, and so difficult-
to-impute SNPs are less likely to produce false positives by chance
when using the Bayes factor than using the likelihood ratio statistic.
To quantify the practical impact of this difference between the
approaches, we compared the power of the BF and LR to
distinguish true positive vs false positive signals, and compared
both these approaches with not performing imputation. Since
Imputation-Based Association Mapping
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nearby SNPs), and since we want to compare methods that are
testing different sets of SNPs (imputation vs no imputation), we
took the approach of defining regions, rather than individual
SNPs, as the unit of ‘‘discovery’’. Specifically, we divided the
chromosome into adjoining 200 kb regions, chosen in such a way
that one region is centered on the causal variant, and scored each
region as a ‘‘discovery’’ if the largest Bayes factor (or the largest
value of L) in that region exceeded some threshold (T, say). Each
discovery was considered a ‘‘true discovery’’ if it contained the
causal variant, and a ‘‘false discovery’’ if it did not. (To reduce the
effects of potential false positives due to LD among regions, we
ignored the regions either side of the region containing the causal
SNP when scoring discoveries as true or false; we also checked that
our qualitative conclusions were insensitive to precise choice of
region size.) Note that, as threshold T decreases, the number of
true discoveries and false discoveries necessarily increases. Note
also that, since the imputation approach involves computing test
statistics for both typed and untyped SNPs, it will inevitably
increase the number of both true and false discoveries (for given T)
compared with testing typed SNPs only. To make a fair
comparison between different approaches we therefore focus on
comparing the number of true discoveries, for a given number of
false discoveries, by plotting the number of true vs. false discoveries
as T varies. Since the relative performance of different methods
was similar for the two simulation scenarios, we show results
averaged across the scenarios.
The results (Figure 4) confirm that the BF has an advantage
compared with the likelihood ratio statistics: for any given number
of true positives, the BF produces fewer false positives. This
Figure 3. Graph showing correspondance between log10(BFmean) values and Likelihood ratio statistics L (left) and Lmean (right).
Each point represents one SNP-phenotype combination, colored according to average confidence in imputed genotypes. Specifically, the SNPs were
colored according to the value of r, defined to be the ratio of the variance of the (posterior mean) genotypes and the expected variance if the SNP
were typed, calculated from the MAF assuming Hardy-Weinberg equilibrium (2f(12f)). This scaling ensures that for typed and confidently-imputed
SNPs r<1, whereas for SNPs with low average confidence r will be close to 0. Colors indicate ranges of values of r: red rM(0,0.001]; green rM(0.001,0.01];
blue rM(0.01,0.1]; cyan rM(0.1,0.5]; black r.0.5.
doi:10.1371/journal.pgen.1000279.g003
Figure 4. Effects of different test statistics on power to detect associations. Each line shows the trade-off between true and false discoveries
when using Bayes factors (black lines) or likelihood ratio test statistics L (red solid lines) and Lmean (red dashed lines), as threshold for declaring an
association is varied. In each setting the Bayes factor produces as good, or better, performance than the likelihood ratio test (black lines are above the
corresponding red lines). Best performance is obtained using CEU panel, which is well-matched to the sample and produces a low imputation error
rate (left; imputation error rate 6.2%). Larger increases in imputation error rate, obtained when using YRI panel that is not well-matched to sample,
produce a notable reduction in performance (right; imputation error rate 25%). However, even with a high imputation error rate, using the Bayes
factor as a test statistic gives better results than no imputation (blue dotted lines in both panel).
doi:10.1371/journal.pgen.1000279.g004
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panel where there are more poorly-imputed SNPs with low
confidence genotypes. For the YRI panel the full likelihood ratio
performed better than Lmean, presumably because the approxi-
mate model on which Lmean is based is a worse approximation for
harder-to-impute SNPs.
Summary of Comparisons of Bayes Factor and Likelihood
Ratio. In summary, when testing imputed variants for
association with a normal phenotype, we found that using a
Bayes factor to rank SNPs for strength of evidence of a association
gave better performance than using the Likelihood ratio statistics.
Theoretical arguments suggest that this gain in performance may
be explained by viewing the Likelihood ratio statistics as making
an implicit, and unnatural assumption: that difficult-to-impute
variants tend to have larger effect sizes. Consistent with this, we
found that the quantitative difference in performance depends on
the fraction of difficult-to-impute SNPs, and is larger when many
SNPs have low-confidence imputed genotypes. Thus, in practice,
the difference between the methods might have greater
importance in imputation applications involving harder-to-
impute rare variants (e.g. where the panel data are resequencing
data, rather than genotype data–a scenario that may be more
common in the near future with gains in sequencing technology).
It is natural to ask whether the advantage of the Bayes factor
over the likelihood ratio statistics in this setting (of normal
phenotype) also transfers to other settings, and to other frequentist
test statistics. In fact we believe there are several reasons to expect
it will apply quite generally. For example, regarding the transfer to
settings other than normal phenotypes, the theoretical results from
[17] apply to logistic regression models. Further, Wakefield’s
results are based on an approximate Bayes factor that itself is
based on asymptotic normality of the maximum likelihood
estimate, and it seems quite probable that similar results can be
obtained in other settings where the maximum likelihood estimate
is asymptotically normal.
Regarding the extension to other frequentist test statistics, we
note that many test statistics in common use (e.g. the F statistic in
standard regression) are asymptotically equivalent to the likelihood
ratio test statistic. Furthermore, we view the root cause of the loss of
power of the likelihood ratio statistics compared with the Bayes
factor as being due to the fact that under the null, by design, the
likelihood ratio statistics have the same distribution for all SNPs. (In
contrast, under the null, the Bayes factors for difficult-to-impute
SNPs tend to be closer to 1 than for other SNPs–Figure 3–reflecting
the fact that there is little information in these SNPs to distinguish
the null and alternative hypotheses.) This design feature limits the
ability of L and Lmean to respond to differences in informativeness
among SNPs, and in particular it causes them to occassionally
produce, by chance, high ranks for difficult-to-impute SNPs. We
therefore expect other test statistics that have this feature of having a
fixed distribution under the null (which would include most
conventional frequentist test statistics used for single-SNP analyses,
including chi-square statistics for case-control studies, and the score
test in [3]) to suffer similar problems. Note that, based on this
insight, one could attempt to design frequentist procedures that
circumvent this problem. For example, one could rank SNPs using
the Bayes factors we present here, and then assess significance of the
largest Bayes factor by permutation, providing a p value for the
global null hypothesis of no association between the genotypes and
phenotypes, and thus controlling the family-wise type I error rate.
Alternatively, and preferably, one could try to design a similar
procedure that ranks SNPs by their Bayes factor, and then controls
the False Discovery Rate [18]. A simpler, and more ad hoc fix, would
be to simply avoid testing SNPs that are difficult to impute; this may
well provide an effective practical solution, although the inevitable
arbitrarinessindecidingwhichSNPsaresufficientlywell-imputedto
test seems inherently unsatisfying.
We emphasise that we do not view the gain in power discussed
here as the only, or indeed the strongest, argument for applying
Bayesian methods: we have focussed on it because it is an issue
specific to imputation analyses, and one that has not previously
been discussed. We also emphasise that the prior we used here,
where effect size depends on minor allele frequency, and with no
dominance, was adopted purely to facilitate comparisons with the
likelihood ratio statistics. If effect sizes are independent of (or only
weakly dependent on) MAF, or if some loci exhibit dominant
effects, then increased power should be obtained from a Bayesian
analysis that incorporate these factors. A strength of the Bayesian
approach is its ability to incorporate this type of information where
it is available, and to average over assumptions where good data
are not available. For example, since there is little direct data on
relationship between the MAF and effect size, there is an
argument for averaging Bayes factors obtained under both the
independence and dependence assumptions; similarly, there is an
argument for averaging Bayes factors over different amounts of
dominance, for example by setting sd.0 (of course, any particular
value of sd is going to be somewhat arbitrary, but setting it to be
small seems preferable to assuming no dominance).
Effect of Imputation Accuracy on Power
Besides comparing the Bayesian and frequentist approaches to
inference, the results in Figure 4 also illustrate that, at least when
using the Bayes factor to test imputed SNPs, the imputation-based
approach is relatively robust to very poor imputation accuracy:
even with very high average imputation error rate (25% error rate
with YRI panel) the imputation-based method using the Bayes
factor as a test statistic performs better than testing typed markers
only. This is reassuring for the use of imputation in studies where
no well-matched panel is available. We also examined the effect of
smaller changes in imputation accuracy (imputation error rates in
range 6.2% to 7.3%). As might be expected, such small changes in
imputation error rate produce correspondingly small changes in
performance (comparable in magnitude to the difference between
BFmean and L for the CEU panel in Figure 4; data not shown).
Binary Phenotypes
While we have focussed here on testing quantitative phenotypes
for association with genotypes, all of the key results should be
expected to also apply to binary (0/1) phenotypes. Indeed,
although the natural way to analyse a binary trait is via a logistic,
rather than a linear, regression, for the small effect sizes that are
typical in genetic studies the two approaches to analysis might be
expected to produce similar results (e.g. see [19], p. 18). To
examine this further, we simulated binary phenotypes Y9, by taking
the quantitative phenotypes Y simulated above, and setting
Y’i~1 Yiw0 ðÞ . We then compared the Bayes factors for these
binary phenotypes under the linear model (using the mean
genotype approximation based on (8)), and the logistic model
[using the Laplace method to approximate necessary integrals, as
was done in 9; see Text S3]. The results (Figure 5) show a strong
correspondence between Bayes factors based on the two different
models, supporting the idea that results obtained here for
quantitative traits will apply also to binary traits.
Discussion
In summary, we have addressed a number of practical issues
that arise in implementing imputation-based association mapping
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model of [7] to impute untyped SNPs, fitting the model to only the
panel produces substantially improved imputation accuracy
compared with fitting the model to all data; ii) although
imputation accuracy is affected by mismatches in genetic
background between panel and study samples, imputed genotypes
can be accurate provided the panel contain at least some samples
that are representative of the study sample; iii) when computing
Bayes factors based on imputed genotypes, simply replacing the
imputed genotypes with their posterior mean produces a good
approximation to a full analysis; iv) when ranking imputed SNPs
for association, in our simulations Bayes factors produced better
rankings than Likelihood ratio statistics; our explanation for this,
based on theoretical arguments, is that the Bayes factors take
better account of the different amounts of information in different
imputed SNPs; v) The power of Bayesian imputation-based
association mapping is relatively robust with respect to imputation
accuracy: even when average imputation accuracy is low,
imputation-based analysis can increase power compared with
testing typed SNPs only. More generally, since in our simulations
small differences in imputation accuracy had only a small effect on
power, we conclude that choice of imputation method may
ultimately matter less than what is done with the imputed
genotypes. Thus, when selecting software to use in performing
imputation-based analyses, it seems important to consider the
range of analyses that can be performed, as well as the imputation
method used. For example, our software, BIMBAM, can perform
not only the single-SNP tests based on Bayes factors described
here, but also multi-SNP analyses of individual genes or regions;
and it can easily exploit any (unphased) resequencing data that
may be available on regions of interest. All these features can
increase power to detect, and ability to explain, associations [2].
While our findings are based on use of a particular imputation
method, in the particular context of association mapping of a
quantitative phenotype, all of them (except perhaps i) above) are
likely to apply more generally. For example, the PAC model used
for imputation in [3] has many similarities with the one we use
here, including the fact that imputation is essentially performed by
modelling each sampled haplotype as a mosaic of template
haplotypes (in the PAC model these template haplotypes are the
panel haplotypes, where in the cluster-based model these template
haplotypes are estimated from the panel haplotypes, and are in
some sense a summary of the panel haplotypes). As such, finding
(ii) regarding the impact of mismatches in genetic background
between panel and cohort individuals are also likely to apply to this
method. Similarly, findings (iii–vi) seem likely to apply not only to
quantitative traits, but also binary traits, or case-control studies,
particularly given the correspondence between the Bayes factors
based on linear and logistic models, in Figure 5.
Although imputation-based analyses involve considerably more
computation than simply testing typed SNPs, these analyses are
nevertheless now practical with very modest computational
resources. For example, using the methods we describe here
(and particularly findings i) and iii) above), implemented in the
software package BIMBAM, analysing the whole of chromosome
22, in 675 individuals, with E=5 and K=10 takes just under an
hour on a single Mac PRO desktop computer (with 3.0 GHz CPU
and 8G memory, although memory used for simulations here was
less than 1G).
Besides the gain in computational convenience, the effectiveness
of Bayes factors based on posterior mean genotypes also has
important implications for sharing and combining data across
studies. Specifically, we have in mind situations where, for
political, ethical, or other reasons, sharing individual-level
genotype and phenotype data among investigators working on
similar studies is more difficult than sharing summary-level data on
each SNP. In these cases, a simple approach is to share and
compare Bayes factors (or p values) for each SNP. However, better
summaries of the data can be easily shared, to allow more
powerful subsequent analyses. Specifically, for a quantitative trait,
for a typed SNP the Bayes factor (8) depends on the phenotype
and genotype data only through the matrices X
tX, X
tY and the
number Y
tY. Similarly, for an imputed SNP, BFmean depends only
on X ¯ tX ¯, X ¯ tY and Y
tY. These three quantities represent only
summary level data (for example, in the case of the observed SNP
they are essentially equivalent to knowing the number of
individuals in each genotype class, and the within-genotype-class
means and standard deviations of the phenotype). Further, if these
three quantities are known for multiple studies, they can be
computed for the combined study. Specifically, if Xs and Ys denote,
respectively, the design matrix and phenotype vector for study s
(s=1,…,S), and X and Y denote the combined design matrix and
phenotype vector for the combination of data across all S studies,
then it is straightforward to show that
XtX~
X S
s~1
Xt
s Xs, XtY~
X S
s~1
Xt
s Ys, YtY~
X S
s~1
Yt
s Ys: ð13Þ
Since X
tX, X
tY and Y
tY suffice to compute the Bayes factor for the
combined study, this demonstrates that, from appropriate
summary-level data from each study, one can compute the Bayes
factor BFmean for each SNP as if one had possession of the combined data
across all studies. (Note that the same summary data also suffice to
compute Lmean, allowing frequentist inference for the joint data
also to be performed without sharing individual-level data.)
Of course, combining results across studies can present many
challenges, including differential inclusion criteria or phenotype
definitions; differential genotyping biases, e.g. due to differential
DNA quality [20]; and different phenotype distributions and/or
genetic backgrounds within different studies. Some of these
problems may be easier to solve than others (e.g. to minimize
this last problem we advocate quantile normalizing the phenotype
values within each study, to an N(0,1) distribution, prior to
computing summary statistics.) However, our results do provide a
Figure 5. The x-axis is log10 (BF) of linear model and y-axis is
log10 BF of logistic model. The blue line is x=y.
doi:10.1371/journal.pgen.1000279.g005
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challenges can be surmounted. Our software BIMBAM includes
an option to output and input summary statistics of this form,
allowing multiple investigators to easily perform a combined
imputation-based analysis of multiple data sets, without sharing
individual level data among groups.
The methods described here, like those from [3], are based on a
prospective likelihood. However, they have already been applied
to other designs, such as case-control studies [9], where use of a
retrospective likelihood would be more appropriate. We now
consider the validity of this approach. For case-control studies,
with observed covariates, the correspondance between Bayesian
analyses based on prospective and retrospective likelihoods is
derived by [21]. In brief, they show that the Bayesian analysis
based on a prospective likelihood is equivalent to a particular
Bayesian analysis using the retrospective likelihood, provided that
the prospective analysis uses an (improper) uniform prior on the
baseline log-odds of the disease (e.g. log-odds of disease for
genotype 0). [This is the prior implemented in our software, and it
can also be shown (MS, unpublished data) that the approximate
BF from [17] can be derived using this prior. This was not the
prior used in [9], although it is unclear how much this matters in
practice.] This result justifies the use of Bayesian methods based on
a prospective model, with an appropriate prior on the baseline log-
odds, for analysing typed SNPs in case-control studies. The result
does not apply directly to unobserved covariates, and hence does
not apply directly to untyped SNPs. However, we note that i) if a
SNP is easy to impute, with high confidence genotypes, then the
result seems likely to hold approximately, since it is almost as if the
SNP is observed; ii) if a SNP is difficult to impute, with very low
confidence genotypes, the Bayes factors from prospective and
retrospective analyses will both be close to 1, since there will be
little information regarding association at such SNPs. Thus, for
SNPs that are very easy or very difficult to impute the prospective
analysis will approximately agree with a retrospective analysis.
This gives grounds for optimism that results from applying these
prospective methods to case-control data will not be generally
misleading. The situation is slightly less clear for data obtained by
genotyping individuals that are at the extremes of a quantitative
phenotype distribution (e.g. [22]), since the [21] result applies to
binary phenotypes. Thus, although we speculate that direct
prospective analyses of the observed quantitative phenotypes will
be generally satisfactory here also, it might be prudent to also
analyse such data treating the two extremes as binary (case-
control) phenotypes.
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